Company / Income Tax
Apellis Pharmaceuticals, Inc. Income Tax History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.7M
FY2025
5-year range
$352.0K / $2.1M
FY2021-FY2025
Trend
+48.2%
vs FY2024
Sector context
#69 of 204
Health Care
What the data says
At $2M, Apellis Pharmaceuticals, Inc.'s income tax ranks #136 of 204 in the Health Care sector. Income Tax has fluctuated over the past 6 years, ranging from $352,000 in FY2021 to $2M in FY2023.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -1.4%.
Improved from $2M to $2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +37.0%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Sector benchmark
#136 of 204 in Health CareTop 66% of 204This company $1.7M Sector average $118.7M
▼
-98.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.4%, indicating a declining trend.
- In FY2025, income tax increased 48.2% year-over-year.
- Ranks #69 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7M | +48.2% |
| FY2024 | $1.2M | -45.5% |
| FY2023 | $2.1M | +218.7% |
| FY2022 | $669.0K | +90.1% |
| FY2021 | $352.0K | -80.9% |
| FY2020 | $1.8M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026